← Open Payments lookup

ALEXANDRA O'MALLEY: Open Payments

NPI 1356927198 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$477 in 21 payments from 11 companies in 2025. Trend: 2023 $30 · 2024 $782 · 2025 $477

Food & beverage: $477
CompanyPaymentsAmount
ABBVIE INC.4$84
Alkermes, Inc.3$79
Axsome Therapeutics, Inc.3$75
Janssen Pharmaceuticals, Inc2$59
Otsuka America Pharmaceutical, Inc.3$54
E.R. Squibb & Sons, L.L.C.1$26
Teva Pharmaceuticals USA, Inc.1$26
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Almatica Pharma LLC1$18

Products named: VRAYLAR, ARISTADA, Auvelity, REXULTI, SPRAVATO, VIVITROL, Sunosi, COBENFY.

Industry payments across MA — which companies pay providers there.